Form 4 for CORZ Core Scientific, Inc./tx
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0000905148-26-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2025-12-31 | CORZ | DUCHENE TODD M | See remarks | A - Grant | $0.00 | +55.8K | 2.08M | +3% | $0 | |
| 2026-01-05 | 2025-12-31 | CORZ | DUCHENE TODD M | See remarks | F - Tax | $15.08 | -139.9K | 1.94M | -7% | -$2.11M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | A | A | 55,758 | $0.00 | 2,077,880 | D | — | — | (F2) Reported amount reflects the acquisition of 694 shares of Common Stock that the Reporting Person received on October 27, 2025 on an involuntary basis for no consideration in an in-kind distribution on a pro rata basis from a reserve of shares of Common Stock held for certain claims settlement matters in connection with previous bankruptcy proceedings of the Issuer, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act. |
| 2 | Common | Common Stock | 2025-12-31 | F | D | 139,873 | $15.08 | 1,938,007 | D | — | — |